Close



Mar 20, 2024 07:00AM
Mar 18, 2024 03:41PM
Mar 18, 2024 01:54PM
Mar 12, 2024 03:30AM
Feb 5, 2024 07:00AM
Feb 2, 2024 07:00AM
Jan 25, 2024 07:00AM Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
Jan 17, 2024 08:00AM
Dec 11, 2023 07:18AM
Dec 11, 2023 07:00AM
Nov 30, 2023 07:00AM
Nov 30, 2023 07:00AM
Nov 13, 2023 07:00AM
Oct 26, 2023 07:00AM Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023
Oct 5, 2023 04:44AM
Oct 5, 2023 03:35AM
Sep 20, 2023 07:41AM
Sep 18, 2023 07:02AM
Sep 18, 2023 07:00AM
Aug 31, 2023 07:00AM
Aug 3, 2023 07:01AM Orchard Therapeutics Plc (ORTX) Completes Submission of BLA for OTL-200 in MLD to U.S. FDA
Aug 3, 2023 07:00AM
Jun 26, 2023 07:08AM
Jun 26, 2023 07:00AM
May 19, 2023 09:01AM
May 19, 2023 09:00AM
May 15, 2023 09:10AM
May 15, 2023 09:08AM Weekly biotech pulse: X4 Pharma data on deck, AbbVie set for FDA review
May 15, 2023 07:00AM
Mar 6, 2023 06:06AM
Mar 6, 2023 06:05AM
Mar 6, 2023 06:05AM
Mar 6, 2023 06:03AM
Mar 6, 2023 06:00AM
Mar 6, 2023 06:00AM Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million
Feb 24, 2023 07:05AM
Feb 24, 2023 07:00AM
Feb 24, 2023 07:00AM
Jan 9, 2023 07:00AM
Jan 9, 2023 07:00AM
Jan 5, 2023 07:01AM
Jan 5, 2023 07:00AM Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
Jan 5, 2023 07:00AM
Dec 12, 2022 07:00AM
Dec 12, 2022 07:00AM
Nov 14, 2022 07:00AM
Nov 14, 2022 07:00AM
Nov 3, 2022 09:05AM
Nov 3, 2022 09:05AM Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
Sep 15, 2022 07:00AM

251,770 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All